Sort
261,768 grants matching “gene therapy”
Toward Safer Gene Therapy for Hemophilia A
$2,492,072Roland W. Herzog · Indiana University Indianapolis · P01 · FY2024 · HL
Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
$2,491,765Michael B Brenner · Brigham And Women'S Hospital · P01 · FY2023 · AI
Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
$2,491,765Michael B Brenner · Brigham And Women'S Hospital · P01 · FY2025 · AI
Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
$2,491,765Michael B Brenner · Brigham And Women'S Hospital · P01 · FY2024 · AI
Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
$2,491,765Michael B Brenner · Brigham And Women'S Hospital · P01 · FY2022 · AI
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm
$2,491,631Daniel B Rifkin · New York University School Of Medicine · P01 · FY2018 · HL
Fred Hutchinson Cancer Research Center Lung SPORE
$2,491,191A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2019 · CA
Chinese American Eye Study
$2,490,307Rohit Varma · University Of Southern California · U10 · FY2012 · EY
Oncolytic Virotherapy in Hepatocellular Cancer
$2,490,000Mitesh Borad · Mayo Clinic Arizona · DP2 · FY2014 · CA
SPORE in Genitourinary Cancer
$2,489,653Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2008 · CA
Breast Cancer Family Registry Cohort
$2,489,620Esther M John · Cancer Prevention Instit Of California · UM1 · FY2014 · CA
HPMI: Host Pathogen Mapping Initiative
$2,489,172Nevan J Krogan · University Of California, San Francisco · U19 · FY2023 · AI
Lipid Metabolism as a Determinant of Ferroptosis Sensitivity in Cancer
$2,489,032Xuejun Jiang · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Brain Tumor Therapeutic Efficacy by Quantitative MR
$2,488,961University Of Michigan At Ann Arbor · P01 · FY2001 · CA
Protection of Ischemic Myocardium
$2,488,563Roberto Bolli · University Of Louisville · P01 · FY2015 · HL
Hematopoiesis in Cardiovascular Disease
$2,488,354Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2025 · HL
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,488,242Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2012 · HL
SPORE in Lung Cancer
$2,487,605University Of Texas Sw Med Ctr/Dallas · P50 · FY2004 · CA
Targeted Therapies in Melanoma
$2,487,446Meenhard Herlyn · Wistar Institute · P01 · FY2021 · CA
Molecular Targeting of Developmental Cancers in Children
$2,487,338Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,486,169Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2021 · HL
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,486,098Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
SPORE IN GASTROINTESTINAL CANCER
$2,485,530Johns Hopkins University · P50 · FY2001 · CA
Targeted Therapies in Melanoma
$2,485,489Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
UCLA Center for AIDS Research (CFAR)
$2,485,000Jerome A. Zack · University Of California Los Angeles · P30 · FY2008 · AI